申请人:SMITHKLINE BEECHAM CORP
公开号:WO2009083526A1
公开(公告)日:2009-07-09
The invention relates to novel benzimidazole compounds of formula (I) wherein R1 to R1 are as defined in the specification, pharmaceutically acceptable salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds that are agonists of peroxisome proliferators-activated receptorγ (PPARγ).
这项发明涉及公式(I)中R1到R1所定义的新型苯并咪唑化合物,其药学上可接受的盐,含有它们的药物组合物以及它们在医学上的用途。具体而言,该发明涉及激动过氧化物酶体增殖物激活受体γ(PPARγ)的激动剂化合物。